• Vitamin B6 (Pyridoxal Phosphate)
  • GSTP1, APC, RASSF1 Promoter Methylation Profiling (ConfirmMDx) for Prostate Cancer
  • HER2/neu (ERBB2), IHC, Semi Quantitative, Automated
  • CDH1 Gene Mutation Analysis
  • Serotonin Receptor HTR2A Genotyping
  • Dehydroepiandrosterone Sulfate (DHEA-S)
  • Cytochrome P450 6A2 (CYP6A2) Genotyping
  • Epstein-Barr Virus (EBV) VCA, IgG
  • NOP10 Gene Mutation Analysis
  • Trypsin-Like Immunoreactivity
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Additional Testing
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.
Loading...